Accelerating Medical Innovation To Enhance Patient Wellbeing
Bridging the gap between global innovation and clinical application. We develop and distribute next-generation technologies for surgeons and patients.
From Thought to a Global Market.
We accelerate medical innovation by bridging the gap between clinical concepts and commercial reality using our proprietary AIM framework.
PBC Biomed
- Home
- PBC Biomed
PBC Biomed – Accelerating Medical Innovation to Enhance Patient Wellbeing
PBC Biomed is dedicated to accelerating medical innovation by supporting the development and commercialization of medical devices, biologics, and pharmaceuticals.
As a strategic consultancy partner, we guide our clients through the complexities of the medical product lifecycle—from initial concept to market launch—focusing particularly on the European and U.S. markets.
Over the past five years, we have delivered our full suite of advanced medical device services to our global portfolio of clients, ranging from technology transfer and manufacturing, right through to commercialization.
In addition to our advanced medical device services, PBC Biomed also has four key affiliate companies, including Biomimetic Innovations, PBC BioHub, PBC Dermal Care and PBC Biovet.
Key Consultancy Partnership: Mochida Pharmaceutical co., Ltd
The PBC Biomed Design & Development, Clinical, Regulatory and Commercial teams have been working alongside Mochida Pharmaceutical Co., Ltd. for the last four years; preparing ReFeel® Nerve Repair Solution for commercial release in the US.
ReFeel® is biocompatible in nature and uses a proprietary alginate and PGA formula to create a bridge for nerve regeneration. It is indicated for the repair of peripheral nerve discontinuities where gap closure can be achieved by flexion of the extremity, or the management of peripheral nerve injuries in which there has been no substantial loss of nerve tissue.